|
1
|
Dejana E: Endothelial cell-cell junctions:
Happy together. Nat Rev Mol Cell Biol. 5:261–270. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brandner JM, Haftek M and Niessen CM:
Adherens junctions, desmosomes and tight junctions in epidermal
barrier function. Open Dermatol J. 4:14–20. 2010. View Article : Google Scholar
|
|
3
|
Förster C: Tight junctions and the
modulation of barrier function in disease. Histochem Cell Biol.
130:55–70. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Niessen CM: Tight junctions/adherens
junctions: Basic structure and function. J Invest Dermatol.
127:2525–2532. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martin TA and Jiang WG: Loss of tight
junction barrier function and its role in cancer metastasis.
Biochim Biophys Acta. 1788:872–891. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schneeberger EE and Lynch RD: The tight
junction: A multifunctional complex. Am J Physiol Cell Physiol.
286:C1213–C1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang GH, Wu L and Yu GY: Tight junctions
and paracellular fluid and ion transport in salivary glands. Chin J
Dent Res. 16:13–46. 2013.PubMed/NCBI
|
|
8
|
Van Itallie CM and Anderson JM: The
molecular physiology of tight junction pores. Physiology
(Bethesda). 19:331–338. 2004.PubMed/NCBI
|
|
9
|
Coradini D, Casarsa C and Oriana S:
Epithelial cell polarity and tumorigenesis: New perspectives for
cancer detection and treatment. Acta Pharmacol Sin. 32:552–564.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee M and Vasioukhin V: Cell polarity and
cancer-cell and tissue polarity as a non-canonical tumor
suppressor. J Cell Sci. 121:1141–1150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morin PJ: Claudin proteins in human
cancer: Promising new targets for diagnosis and therapy. Cancer
Res. 65:9603–9606. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tabariès S and Siegel PM: The role of
claudins in cancer metastasis. Oncogene. 36:1176–1190. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
González-Mariscal L, Tapia R and Chamorro
D: Crosstalk of tight junction components with signaling pathways.
Biochim Biophys Acta. 1778:729–756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oliveira S and Morgado-Díaz JA: Claudins:
Multifunctional players in epithelial tight junctions and their
role in cancer. Cell Mol Life Sci. 64:17–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morita K, Furuse M, Fujimoto K and Tsukita
S: Claudin multigene family encoding four-transmembrane domain
protein components of tight junction strands. Proc Natl Acad Sci.
96:511–516. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krause G, Winkler L, Mueller SL, Haseloff
RF, Piontek J and Blasig IE: Structure and function of claudins.
Biochim Biophy Acta. 1778:631–645. 2008. View Article : Google Scholar
|
|
17
|
Elkouby-Naor L and Ben-Yosef T: Functions
of claudin tight junction proteins and their complex interactions
in various physiological systems. Int Rev Cell Mol Biol. 279:1–32.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Findley MK and Koval M: Regulation and
roles for claudin-family tight junction proteins. IUBMB Life.
61:431–437. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lal-Nag M and Morin PJ: The claudins.
Genome Biol. 10:2352009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ikari A, Sato T, Watanabe R, Yamazaki Y
and Sugatani J: Increase in claudin-2 expression by an
EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.
Biochim Biophy Acta. 1823:1110–1118. 2012. View Article : Google Scholar
|
|
21
|
Itoh M, Furuse M, Morita K, Kubota K,
Saitou M and Tsukita S: Direct binding of three tight
junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH
termini of claudins. J Cell Biol. 147:1351–1363. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D'Souza T, Agarwal R and Morin PJ:
Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent
protein kinase regulates tight junction barrier function in ovarian
cancer cells. J Biol Chem. 280:26233–26240. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Souza T, Indig FE and Morin PJ:
Phosphorylation of claudin-4 by PKCepsilon regulates tight junction
barrier function in ovarian cancer cells. Exp Cell Res.
313:3364–3375. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kominsky SL: Claudins: Emerging targets
for cancer therapy. Expert Rev Mol Med. 8:1–11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Furuse M and Tsukita S: Claudins in
occluding junctions of humans and flies. Trends Cell Biol.
16:181–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Günzel D and Alan S: Claudins and the
modulation of tight junction permeability. Physiol Rev. 93:525–569.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ouban A and Ahmed AA: Claudins in human
cancer: A review. Histol Histopathol. 25:83–90. 2010.PubMed/NCBI
|
|
28
|
Osanai M, Takasawa A, Murata M and Sawada
N: Claudins in cancer: Bench to bedside. Pflugers Arch. 469:55–67.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kwon MJ: Emerging roles of claudins in
human cancer. Int J Mol Sci. 14:18148–18180. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Katai H, Yoshimura K, Maruyama K, Sasako M
and Sano T: Evaluation of the New International Union Against
Cancer TNM staging for gastric carcinoma. Cancer. 88:1796–1800.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pan XY, Wang B, Che YC, Weng ZP, Dai HY
and Peng W: Expression of claudin-3 and claudin-4 in normal,
hyperplastic, and malignant endometrial tissue. Int J Gynecol
Cancer. 17:233–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Yang H, McNutt MA, Xiong F, Nie X,
Li L and Zhou R: LAPTM4B overexpression is an independent
prognostic marker in ovarian carcinoma. Oncol Rep. 20:1077–1083.
2008.PubMed/NCBI
|
|
34
|
Lin Z, Zhang X, Liu Z, Liu Q, Wang L, Lu
Y, Liu Y, Wang M, Yang M, Jin X and Quan C: The distinct expression
patterns of claudin-2, −6, and −11 between human gastric neoplasms
and adjacent non-neoplastic tissues. Diagn Pathol. 8:1332013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu Z: Functions of claudin-7 in human lung
cancer. 2012.
|
|
36
|
Hewitt KJ, Agarwal R and Morin PJ: The
claudin gene family: Expression in normal and neoplastic tissues.
BMC Cancer. 6:1862006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kominsky SL, Argani P, Korz D, Evron E,
Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S:
Loss of the tight junction protein claudin-7 correlates with
histological grade in both ductal carcinoma in situ and invasive
ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singh AB, Sharma A and Dhawan P: Claudin
family of proteins and cancer: An overview. J Oncol.
2010:5419572010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Swisshelm K, Macek R and Kubbies M: Role
of claudins in tumorigenesis. Adv Drug Deliv Rev. 57:919–928. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Webb PG, Spillman MA and Baumgartner HK:
Claudins play a role in normal and tumor cell motility. BMC Cell
Biol. 14:192013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rangel LB, Agarwal R, D'Souza T, Pizer ES,
Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR and Morin PJ:
Tight junction proteins claudin-3 and claudin-4 are frequently
overexpressed in ovarian cancer but not in ovarian cystadenomas.
Clin Cancer Res. 9:2567–2575. 2003.PubMed/NCBI
|
|
42
|
Szász MA: Claudins as prognostic factors
of breast cancer. Magy Onkol. 56:209–212. 2012.(In Hungarian).
PubMed/NCBI
|
|
43
|
Zhang X, Ruan Y, Li Y, Lin D, Liu Z and
Quan C: Expression of apoptosis signal-regulating kinase 1 is
associated with tight junction protein claudin-6 in cervical
carcinoma. Int J Clin Exp Pathol. 8:5535–5541. 2015.PubMed/NCBI
|
|
44
|
Wang H and Yang X: The expression patterns
of tight junction protein claudin-1, −3, and −4 in human gastric
neoplasms and adjacent non-neoplastic tissues. Int J Clin Exp
Pathol. 8:881–887. 2015.PubMed/NCBI
|
|
45
|
Zhu J and Wang R, Cao H, Zhang H, Xu S,
Wang A, Liu B, Wang Y and Wang R: Expression of claudin-5, −7, −8
and −9 in cervical carcinoma tissues and adjacent non-neoplastic
tissues. Int J Clin Exp Pathol. 8:9479–9486. 2015.PubMed/NCBI
|
|
46
|
Huang J, Li J, Qu Y, Zhang J, Zhang L,
Chen X, Liu B and Zhu Z: The expression of claudin 1 correlates
with β-catenin and is a prognostic factor of poor outcome in
gastric cancer. Int J Oncol. 44:1293–1301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu JL, Gao P, Wang ZN, Song YX, Li AL, Xu
YY, Wang MX and Xu HM: Clinicopathological significance of
claudin-4 in gastric carcinoma. World J Surg Oncol. 11:1502013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gao M, Li W, Wang H and Wang G: The
distinct expression patterns of claudin-10, −14, −17 and E-cadherin
between adjacent non-neoplastic tissues and gastric cancer tissues.
Diagn Pathol. 8:2052013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lu Y, Jing J, Sun L, Gong Y, Chen M, Wang
Z, Sun M and Yuan Y: Expression of claudin-11, −23 in different
gastric tissues and its relationship with the risk and prognosis of
gastric cancer. PLoS One. 12:e01744762017. View Article : Google Scholar : PubMed/NCBI
|
